A detailed history of Goal Vest Advisory LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Goal Vest Advisory LLC holds 971 shares of SAVA stock, worth $2,854. This represents 0.01% of its overall portfolio holdings.

Number of Shares
971
Previous 971 -0.0%
Holding current value
$2,854
Previous $11,000 154.55%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$12.35 - $26.11 $2,778 - $5,874
225 Added 30.16%
971 $11,000
Q1 2023

Apr 03, 2023

BUY
$23.46 - $36.44 $5,513 - $8,563
235 Added 45.99%
746 $17,000
Q4 2022

Jan 06, 2023

BUY
$27.82 - $44.16 $111 - $176
4 Added 0.79%
511 $0
Q3 2022

Oct 11, 2022

BUY
$16.33 - $51.06 $195 - $612
12 Added 2.42%
507 $21,000
Q2 2022

Jul 06, 2022

SELL
$17.22 - $38.47 $15,101 - $33,738
-877 Reduced 63.92%
495 $13,000
Q1 2022

May 03, 2022

BUY
$32.6 - $53.05 $44,727 - $72,784
1,372 New
1,372 $51,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $118M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Goal Vest Advisory LLC Portfolio

Follow Goal Vest Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goal Vest Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goal Vest Advisory LLC with notifications on news.